Latest News about NVAX
Recent news which mentions NVAX
What's Next For Novavax Stock?
January 29, 2022
From Motley Fool
3 Things About BioNTech That Smart Investors Know
January 29, 2022
From Motley Fool
Why Novavax Stock Surged 14% on Friday
January 28, 2022
From Motley Fool
Novavax Could Be the Biggest Bargain in the Market Right Now
January 28, 2022
From InvestorPlace
World hits milestone of 10 billion COVID vaccine doses administered, but less than 10% of people in low-income countries have had a first jab
January 28, 2022
From MarketWatch
Why Novavax Stock Is Sinking Again This Week
January 27, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
From Benzinga
1 Top Biotech Stock Ready for a Bull Run
January 27, 2022
From Motley Fool
Better Growth Stock: Novavax vs. Teladoc
January 27, 2022
From Motley Fool
4 of the Fastest-Growing Stocks on the Planet in 2022
January 27, 2022
From Motley Fool
Why Coronavirus Vaccine Stocks Topped the Market Today
January 26, 2022
From Motley Fool
From InvestorPlace
Novavax Continues to Require Patience, But It Should Pay Off
January 25, 2022
From InvestorPlace
Down 57% in 1 Month, Is Novavax a Bargain Buy?
January 25, 2022
From Motley Fool
Novavax Appears to be Running Out of Options
January 25, 2022
From InvestorPlace
3 Top Stocks That Can Make You Richer in January (and Beyond)
January 25, 2022
From Motley Fool
Why Vaccine Stocks Like Moderna and Novavax Tumbled (Again) Today
January 24, 2022
From Motley Fool
Where Will BioNTech Be in 3 Years?
January 24, 2022
From Motley Fool
1 Green Flag for Novavax in 2022, and 1 Red Flag
January 23, 2022
From Motley Fool
The Worst Mistake Moderna Investors Can Make in 2022
January 22, 2022
From Motley Fool
Worldwide Adoption of Novavax Vaccines Makes It a Winner
January 21, 2022
From InvestorPlace
2 Growth Stocks That Could Take Off in February
January 21, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022
January 21, 2022
From Benzinga
Why Novavax Stock Tumbled on Thursday
January 20, 2022
From Motley Fool
Novavax Stock is in a Tough Spot, but its Fortunes Could Improve
January 20, 2022
From InvestorPlace
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.